Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

21Shares launches weekly and monthly options for its Hyperliquid ETF on Nasdaq

Market News
22 Jun 2026
Crypto Briefing
View Source
Bullish
pluang ai news

21Shares has introduced weekly and monthly options trading for its Hyperliquid ETF (ticker THYP) on Nasdaq, just six weeks after the ETF's May 11, 2026 launch. This ETF offers direct exposure to the HYPE token of the Hyperliquid blockchain, integrating staking rewards and charging a 0.30% fee. The new options provide investors with flexible strategies for hedging, income generation, and trading volatility. This move enhances institutional investors' ability to manage risk and capitalize on price movements in the emerging Hyperliquid ecosystem.

More News

General Fusion achieves 8.4 million °C plasma heating, nearing key 1 keV milestone with LM26 fusion machine

General Fusion achieves 8.4 million °C plasma heating, nearing key 1 keV milestone with LM26 fusion machine

General Fusion has made significant progress with its LM26 Magnetized Target Fusion machine, achieving plasma electron temperatures of about 8.4 million degrees Celsius (0.72 keV), nearing its 1 keV target. This milestone demonstrates effective plasm...

Others
Bullish
1 hour ago
AI/R advances AI integration in business with Databricks, achieving Gold partner status and boosting client results.

AI/R advances AI integration in business with Databricks, achieving Gold partner status and boosting client results.

AI/R, a technology company specializing in Agentic AI, has deepened its partnership with Databricks, achieving Gold partner status and expanding its certifications from 11 to over 100. This growth enables AI/R to deliver advanced AI and data solution...

Market News
Bullish
2 hours ago
Lebrikizumab sustains atopic dermatitis clearance up to 2 years with less frequent dosing, per new long-term data.

Lebrikizumab sustains atopic dermatitis clearance up to 2 years with less frequent dosing, per new long-term data.

New long-term data from the ADjoin trial shows that lebrikizumab, an injectable treatment for moderate to severe atopic dermatitis, maintains skin clearance and reduces itching for up to 2 years even with monthly dosing instead of biweekly. About 76%...

Market News
Bullish
3 hours ago
Greystone hires Joshua Rosen to lead seniors housing and healthcare loan origination.

Greystone hires Joshua Rosen to lead seniors housing and healthcare loan origination.

Greystone, a national commercial real estate finance company, has appointed Joshua Rosen as Senior Managing Director to focus on originating loans for seniors housing and healthcare sectors. Based in Chicago, Rosen brings extensive experience from Wa...

Market News
Bullish
3 hours ago
Investigations launched into merger deals of Apogee, Roku, TruBridge, and Organon over shareholder value concerns.

Investigations launched into merger deals of Apogee, Roku, TruBridge, and Organon over shareholder value concerns.

Brodsky & Smith LLC announced investigations into the merger agreements of Apogee Therapeutics, Roku, TruBridge, and Organon. Each investigation questions whether the respective company boards fulfilled their fiduciary duties by ensuring a fair proce...

Market News
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App